देश: आयरलैंड
भाषा: अंग्रेज़ी
स्रोत: HPRA (Health Products Regulatory Authority)
Carprofen
Norbrook Laboratories Limited
QM01AE91
Carprofen
5 percent weight/volume
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cattle, Horses
carprofen
N.S.A.I.D.
Authorised
2005-09-09
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Norocarp Large Animal 5 %w/v Solution for Injection for young cattle, horses and ponies 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear colourless to pale yellow solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Young cattle (under 12 months of age), horses and ponies. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In young cattle (under 12 months old) Norocarp Large Animal Injection is indicated as adjunctive therapy for the control of acute inflammation associated with respiratory disease. The cause of the condition should be determined and treated with an appropriate antimicrobial. In horses and ponies it is indicated for analgesic and anti-inflammatory action in musculo-skeletal disorders and after surgery. 4.3 CONTRAINDICATIONS Do not use in animals suffering from cardiac, hepatic or renal impairment. Do not use in animals suffering from gastro-intestinal ulceration or bleeding. Do not use where there is evidence of a blood dyscrasia. Do not use in animals with known hypersensitivity to the product. Do not use in pregnant animals. Not permitted for use in lactating cattle producing milk for human consumption. Active substance Carprofen 5.00 % w/v Excipients Ethanol (anhydrous) 10.00 % v/v (as preservative) Sodium Formaldehyde Sulphoxylate 0.20 % w/v (as antioxidant) I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _1_ _4_ _ पूरा दस्तावेज़ पढ़ें